A New York-based biotech was turning heads during Tuesday’s session after the company announced that interim results from a phase 2a trial of its HT-001 showed that all...

To read the full story on AllPennyStocks.com, click here.

Hoth Therapeutics (NASDAQ:HOTH)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Hoth Therapeutics.
Hoth Therapeutics (NASDAQ:HOTH)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Hoth Therapeutics.